Deltec Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Deltec Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$647K	–	238
2025 Q4	$647K	Buy	+30,000	New	+$582K	0.11%	117

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Deltec Asset Management's AVDL Position: Q1 2026 in Review

Deltec Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 30,000 shares — an estimated $647K sold.

Deltec Asset Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $647K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Deltec Asset Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Deltec Asset Management sold 30,000 Avadel Pharmaceuticals shares in Q1 2026, an estimated $647K.
Deltec Asset Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Deltec Asset Management's Avadel Pharmaceuticals position peaked at $647K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Deltec Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.